MetaADEDB 2.0 @ LMMD
enrasentan
(GLCKXJLCYIJMRB-UPRLRBBYSA-N)
Structure
SMILES
CCCOc1ccc2c(c1)[C@H]([C@@H]([C@H]2c1ccc2c(c1)OCO2)C(=O)O)c1ccc(cc1OCCO)OC
Type(s)
Investigational
Molecular Formula:
C29H30O8
Molecular Weight:
506.544
Log P:
4.5620
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
2
TPSA:
103.68
CAS Number(s):
167256-08-8
Synonym(s)
1.
enrasentan
2.
(1S,2R,3S)-3-(2-(2-Hydroxyethoxy)-4-methoxyphenyl)-1-(3,4- (methylenedioxy)phenyl)-5-propoxy-2-indancarboxylic acid
3.
3-(2-(2-hydroxyeth-1-yloxy)-4-methoxyphenyl)-1-(3,4-methylenedioxyphenyl)-5-(prop-1-yloxy)indan-2-carboxylic acid
4.
SB 217242
5.
SB-217242
External Link(s)
MeSHC098288
PubChem Compound178103
BindingDB50061077
CHEMBLCHEMBL431651
DrugBankDB06460
Therapeutic Target DatabaseD07YHT
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Heart failure16219361CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.